Thoracic radiation therapy in limited stage small-cell lung cancer: Timing is everything ... isn't it?

被引：8

作者：

Perry, Michael C. ^{[1
]}

机构：

[1] Univ Missouri, Ellis Fischel Canc Ctr, Columbia, MO 65211 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 24期

关键词：

D O I：

10.1200/JCO.2006.07.2827

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3815 / 3816

页数：2

共 10 条

[1] PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG-CANCER IN COMPLETE REMISSION
ARRIAGADA, R
LECHEVALIER, T
BORIE, F
RIVIERE, A
CHOMY, P
MONNET, I
TARDIVON, A
VIADER, F
TARAYRE, M
BENHAMOU, S
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (03): : 183 - 190
[2] Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: Repopulation as a cause of treatment failure?
Brade, AM
Tannock, IF
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) : 1020 - 1022
[3] Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
De Ruysscher, D
Pijls-Johannesma, M
Bentzen, SM
Minken, A
Wanders, R
Lutgens, L
Hochstenbag, M
Boersma, L
Wouters, B
Lammering, G
Vansteenkiste, J
Lambin, P
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) : 1057 - 1063
[4] Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer
Fried, DB
Morris, DE
Poole, C
Rosenman, JG
Halle, JS
Detterbeck, FC
Hensing, TA
Socinski, MA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) : 4837 - 4845
[5] IMPORTANCE OF TIMING FOR THORACIC IRRADIATION IN THE COMBINED MODALITY TREATMENT OF LIMITED-STAGE SMALL-CELL LUNG-CANCER
MURRAY, N
COY, P
PATER, JL
HODSON, I
ARNOLD, A
ZEE, BC
PAYNE, D
KOSTASHUK, EC
EVANS, WK
DIXON, P
SADURA, A
FELD, R
LEVITT, M
WIERZBICKI, R
AYOUB, J
MAROUN, JA
WILSON, KS
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (02) : 336 - 344
[6] Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: An update of Cancer and Leukemia Group B study 8083
Perry, MC
Herndon, JE
Eaton, WL
Green, MR
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) : 2466 - 2467
[7] A METAANALYSIS OF THORACIC RADIOTHERAPY FOR SMALL-CELL LUNG-CANCER
PIGNON, JP
ARRIAGADA, R
IHDE, DC
JOHNSON, DH
PERRY, MC
SOUHAMI, RL
BRODIN, O
JOSS, RA
KIES, MS
LEBEAU, B
ONOSHI, T
OSTERLIND, K
TATTERSALL, MHN
WAGNER, H
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (23) : 1618 - 1624
[8] Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: A London Lung Cancer Group multicenter randomized clinical trial and meta-analysis
Spiro, Stephen G.
James, Lindsay E.
Rudd, Robin M.
Trask, Colin W.
Tobias, Jeffrey S.
Snee, Michael
Gilligan, David
Murray, Philip A.
Carmen Ruiz de Elvira, Mary
O'Donnell, Katy M.
Gower, Nicole H.
Harper, Peter G.
Hackshaw, Allan K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3823 - 3830
[9] Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104
Takada, M
Fukuoka, M
Kawahara, M
Sugiura, T
Yokoyama, A
Yokota, S
Niskiwaki, Y
Watanabe, K
Noda, K
Tamura, T
Fukuda, H
Saijo, N
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) : 3054 - 3060
[10] Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
Turrisi, AT
Kim, K
Blum, R
Sause, WT
Livingston, RB
Komaki, R
Wagner, H
Aisner, S
Johnson, DH
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04) : 265 - 271

← 1 →